# Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)

> **NCT04763512** · NA · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 200 (actual)

## Conditions studied

- Atopic Dermatitis
- Skin Condition

## Interventions

- **DIETARY_SUPPLEMENT:** Intact Cow's Milk Protein Formula
- **DIETARY_SUPPLEMENT:** Partially Hydrolysed Whey Formula

## Key facts

- **NCT ID:** NCT04763512
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-06
- **Primary completion:** 2023-09-19
- **Final completion:** 2024-11-02
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-06-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04763512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04763512, "Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04763512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*